MAP Congress (Molecular Analysis for Precision Oncology)

Topics covered will include cancer prevention, interception, epigenetics, metastasis, and cancer progression, providing an in-depth understanding of the mechanisms of progression and resistance. Participants will also explore the impact of artificial intelligence in revolutionizing diagnostics and therapies, as well as advances in cancer immunology and new generations of immunotherapies.

Key topics include aging and senescence, interactions with the microbiome linking basic research to clinical applications, and metabolic dysregulation, targeting the therapeutic vulnerabilities of cancer cells to encourage innovative treatments.

Organized in partnership with Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, MAP 2025 offers a program at the forefront of cancer research and care. The scientific co-chairs for this edition are Lisa Derosa (Unicancer, Villejuif, France), Mariam Jamal-Hanjani (CRUK, London, United Kingdom) and Joaquin Mateo (ESMO, Barcelona, Spain).